<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="98659">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01820273</url>
  </required_header>
  <id_info>
    <org_study_id>MRD-Study</org_study_id>
    <nct_id>NCT01820273</nct_id>
  </id_info>
  <brief_title>Changes in Incretine Response and Glycemic Control After Gastric Bypass Surgery in Type 2 Diabetic Patients Versus Healthy</brief_title>
  <official_title>Study of Incretine Response and Glycemic Control: Pre Diet, After Conventional Weight Loss and in the Early Postoperative Phase After Gastric Bypass in T2D-patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kalmar County Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lund University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the early changes in gut hormonal, and other
      metabolites with known relations to the glycemic homeostasis. The study mainly focus on
      these responses to food in the diabetic patient, compared to the non-diabetic, after gastric
      bypass surgery. Also aiming for recording changes in the earliest postoperative phase.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>changes in incretines in the bariatric patient</measure>
    <time_frame>2 months prior to surgery - 6 weeks post surgery</time_frame>
    <description>standardized meals prior to pre op diet, day before surgery, first day after surgery and 6 weeks after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes control</measure>
    <time_frame>6 weeks post surgery</time_frame>
    <description>resolution of t2D as early as first day after surgery</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Obesity</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bloodsamples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        female obese (BMI&gt;35)patients accepted for bariatric surgery (lap gastric bypass). 10
        patients with type 2 diabetes(T2D) 6 10 matched controls without T2D.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of type 2 diabetes

          -  obesity BMI &gt;35

        Exclusion Criteria:

          -  prior bariatric surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nils Wierup</last_name>
    <role>Study Director</role>
    <affiliation>Lunds Universitet, Clinical researchcenter</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johan Berggren, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lunds Universitet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kalmar County Hospital</name>
      <address>
        <city>Kalmar</city>
        <zip>39185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johan Berggren, MD</last_name>
      <phone>+46707364671</phone>
      <email>dr.berggren@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Johan Berggren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 23, 2013</lastchanged_date>
  <firstreceived_date>March 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lund University</investigator_affiliation>
    <investigator_full_name>Johan Berggren</investigator_full_name>
    <investigator_title>M.D</investigator_title>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Bariatric surgery</keyword>
  <keyword>incretines</keyword>
  <keyword>GLP-1</keyword>
  <keyword>GIP</keyword>
  <keyword>gastric bypass</keyword>
  <keyword>foregut</keyword>
  <keyword>hindgut</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
